News Image

Why NYSE:RMD provides a good dividend, while having solid fundamentals.

By Mill Chart

Last update: Jan 17, 2024

Unearth the potential of RESMED INC (NYSE:RMD) as a dividend stock recommended by our stock screening tool. NYSE:RMD maintains a robust financial footing and delivers a sustainable dividend. We'll delve into the details below.

Evaluating Dividend: NYSE:RMD

ChartMill provides a Dividend Rating for every stock, ranging from 0 to 10. This rating assesses various dividend aspects, including yield, growth, and sustainability. NYSE:RMD earns a 7 out of 10:

  • Compared to an average industry Dividend Yield of 1.63, RMD pays a better dividend. On top of this RMD pays more dividend than 94.47% of the companies listed in the same industry.
  • RMD has paid a dividend for at least 10 years, which is a reliable track record.
  • RMD has not decreased their dividend for at least 10 years, which is a reliable track record.
  • RMD pays out 29.17% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of RMD is growing, but earnings are growing more, so the dividend growth is sustainable.

Assessing Health for NYSE:RMD

ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NYSE:RMD, the assigned 7 reflects its health status:

  • An Altman-Z score of 8.44 indicates that RMD is not in any danger for bankruptcy at the moment.
  • RMD's Altman-Z score of 8.44 is amongst the best of the industry. RMD outperforms 88.44% of its industry peers.
  • RMD has a debt to FCF ratio of 1.72. This is a very positive value and a sign of high solvency as it would only need 1.72 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.72, RMD belongs to the best of the industry, outperforming 90.95% of the companies in the same industry.
  • A Debt/Equity ratio of 0.32 indicates that RMD is not too dependend on debt financing.
  • RMD has a Current Ratio of 2.99. This indicates that RMD is financially healthy and has no problem in meeting its short term obligations.

Profitability Assessment of NYSE:RMD

ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NYSE:RMD was assigned a score of 8 for profitability:

  • RMD's Return On Assets of 13.45% is amongst the best of the industry. RMD outperforms 95.98% of its industry peers.
  • RMD's Return On Equity of 21.33% is amongst the best of the industry. RMD outperforms 94.47% of its industry peers.
  • The Return On Invested Capital of RMD (15.86%) is better than 96.48% of its industry peers.
  • RMD has a Profit Margin of 20.72%. This is amongst the best in the industry. RMD outperforms 94.97% of its industry peers.
  • RMD's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 26.62%, RMD belongs to the best of the industry, outperforming 96.98% of the companies in the same industry.
  • In the last couple of years the Operating Margin of RMD has grown nicely.

More Best Dividend stocks can be found in our Best Dividend screener.

Our latest full fundamental report of RMD contains the most current fundamental analsysis.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

RESMED INC

NYSE:RMD (4/22/2024, 6:00:00 PM)

After market: 180.35 0 (0%)

180.35

+1.5 (+0.84%)

RMD News

News Image11 hours ago - ChartmillWondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.

Which S&P500 stocks are moving before the opening bell on Monday?

News Image4 days ago - Market News VideoRMD June 21st Options Begin Trading
News Image4 days ago - Investor's Business DailyHow The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher

ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.

News Image4 days ago - ChartmillDiscover the top S&P500 movers in Thursday's pre-market session and stay informed about market dynamics.

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

News Image5 days ago - The Motley FoolWhy Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank

The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.

News Image5 days ago - Yahoo FinanceWhy Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank

The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.

News Image5 days ago - ChartmillThese S&P500 stocks are moving in today's session

These S&P500 stocks are moving in today's session

News Image5 days ago - Market News VideoWednesday Sector Laggards: Healthcare, Technology & Communications
News Image5 days ago - Market News VideoNotable Wednesday Option Activity: RMD, HES, STLD
News Image5 days ago - ChartmillLet's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.

News Image5 days ago - ChartmillWhich S&P500 stocks are moving on Wednesday?

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

News Image5 days ago - Investor's Business DailyEli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test

The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea.

RMD Links
Follow us for more